Key Points
- CEO Yoshiyuki Aikawa sold 3,100,000 shares on April 21 at $3.02 each (≈$9.36M) and had previously sold 4,422,900 shares on March 6 at $2.12 (≈$9.38M), totaling about 7.52M shares and roughly $18.74M in proceeds; after the April 21 sale he owns 79,304,460 shares (~$239.5M), a 3.76% reduction in that position.
- SBC trades with a market cap of about $348.8M and a P/E of 6.94, reported $0.14 EPS (beating estimates) but revenue below expectations at $39.57M, and carries a consensus analyst rating of Hold with an $8.50 price target amid mixed Buy/Sell coverage.
SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) CEO Yoshiyuki Aikawa sold 3,100,000 shares of the stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $3.02, for a total value of $9,362,000.00. Following the completion of the transaction, the chief executive officer directly owned 79,304,460 shares in the company, valued at $239,499,469.20. The trade was a 3.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Yoshiyuki Aikawa also recently made the following trade(s):
- On Friday, March 6th, Yoshiyuki Aikawa sold 4,422,900 shares of SBC Medical Group stock. The shares were sold at an average price of $2.12, for a total value of $9,376,548.00.
SBC Medical Group Stock Performance
NASDAQ:SBC opened at $3.40 on Friday. SBC Medical Group Holdings Incorporated has a 1-year low of $2.97 and a 1-year high of $5.75. The business's 50-day moving average price is $4.01 and its two-hundred day moving average price is $4.02. The company has a current ratio of 3.78, a quick ratio of 3.74 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $348.77 million, a price-to-earnings ratio of 6.94 and a beta of 0.99.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last released its earnings results on Friday, March 27th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.01. SBC Medical Group had a return on equity of 20.76% and a net margin of 29.37%.The firm had revenue of $39.57 million for the quarter, compared to analyst estimates of $45.19 million. On average, equities analysts expect that SBC Medical Group Holdings Incorporated will post 0.47 earnings per share for the current year.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. Weiss Ratings restated a "sell (d+)" rating on shares of SBC Medical Group in a report on Friday, March 27th. BTIG Research assumed coverage on SBC Medical Group in a report on Friday, March 6th. They issued a "buy" rating and a $8.00 price target for the company. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $8.50.
Get Our Latest Stock Analysis on SBC
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of SBC. Geode Capital Management LLC bought a new position in shares of SBC Medical Group during the second quarter worth about $455,000. XTX Topco Ltd bought a new position in shares of SBC Medical Group during the second quarter worth about $64,000. New York State Common Retirement Fund bought a new position in shares of SBC Medical Group during the second quarter worth about $104,000. Millennium Management LLC bought a new position in shares of SBC Medical Group during the third quarter worth about $219,000. Finally, Williams & Novak LLC bought a new position in shares of SBC Medical Group during the fourth quarter worth about $65,000. 60.82% of the stock is currently owned by institutional investors.
SBC Medical Group Company Profile
(
Get Free Report)
SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.
The company's primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
